COVID-19, long COVID and the rheumatologist with Leonard Calabrese, DO
Description
What should rheumatologists know about what we've learned about COVID-19 and long COVID in 2023? Hosted by Dr. Leonard Calabrese.
· Intro 0:11
· In this episode 0:21
· 2023: current status and controversies 0:35
· What is going on with COVID-19? 01:53
· What do we know about vaccine responses? What should we be telling our patients about vaccines in our immunocompromised population? 2:58
· Lancet Rheumatology MELODY study summary 3:08
· What about patients within the rheumatic and autoimmune disease space? 4:15
· Who is immunocompromised and why does it matter? 5:11
· What is the immunosuppression we are giving them? 6:39
· What to tell patients about getting vaccinated 8:56
· Long COVID 10:09
· What is long COVID? 10:26
· JAMA Network Open study on prevalence and characteristics associated with post-COVID conditions 14:19
· In the clinical arena, what should rheumatologists be thinking about? 16:38
· What about pathogenesis? What do we know about the controversies in this area? 18:58
· Autoimmunity: COVID-19 and autoimmune response 20:45
· What about therapies? 22:22
· The next generation of rheum agents: Immunomodulation with neonatal Fc receptor targeting? 24:40
· A question for the rheumatology community: do patients with immune mediated diseases get more long COVID than the control population? 25:40
· In conclu
United States
